Figure 3From: The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancerKaplan-Meier survival curves for the patients receiving dendritic cells-based vaccination. (Left) Survival curve from diagnosis (dotted line) and from the first vaccination (solid line). (Right) Comparison of the overall survival rates according to albumin levels (≥4.0 g/dL [solid line] and <4.0 g/dL [dotted line]).Back to article page